Bilal A Mir

About

I am a medical doctor and research scientist.I did my bachelors ( MBBS ) and masters ( MD ) in Internal medicine. Subsequently I did doctorate ( DM ) in Gastroenterology and Hepatology and then successfully completed post DM fellowship in advanced GI Endoscopy.
I recieved the Best Interactive DM award by indian Society of Gastroenterology in gastroenterology young masters ( GYM 23 ) meet held in Delhi. Subsequently I was felicitated by best DM research thesis award by indian Society of Gastroenterology at ISGCON held in bangluru 2023. I also qualified for young investigator award among top 5 at position 3 in INASL meet held in Bhabuneshwar.
I have Publications in Worlds best journals including NEJM, Lancet , American Journal of Gastroenterology, journal of Clinical Gastroenterology and Hepatology, Journal of Clinical and Experimental Hepatology, indian Journal of Gastroenterology and others.I am the lead Author of 𝙎𝙑𝙄𝙉 𝙏𝙧𝙞𝙖𝙡.
My area of expertise includes gastrointestinal , hepatobiliary and pancreatic diseases with special interest in MASLD/MASH, Cirrhosis, IBD, and advanced endoscopy'.
I'm am an active and life member of various national and international Societies including ASGE, WEO, WGO, ISG, INASL, SGEI and EFI.
I am currently a practicing Gastroenterlogist, Hepatologist and Therapeutic Endoscopist.
Always keen to do academic activities and active research. Seeking an opportunity to use a decade of experience to serve the needy population.

Employment

• Ujala cygnus superspecialty hospital Consultant
  2024 - Present
• Patel Hospital Consultant cum post Doctorate fellow in AGIE
  2024 - 2024

Education

• Shri Maharaja Hari Singh Hospital Registrar
  2018 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study
  Journal of Family Medicine and Primary Care 2025 DOI: 10.4103/jfmpc.jfmpc_1208_23
  +Save
• A Prospective Randomised Comparative Four-arm Intervention Study of Efficacy and Safety of Saroglitazar and Vitamin E in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)-SVIN TRIAL
  Journal of Clinical and Experimental Hepatology 2024 DOI: 10.1016/j.jceh.2024.101398
  +Save
• Procalcitonin-guided use of antibiotics in acute pancreatitis
  The Lancet Gastroenterology & Hepatology 2022 DOI: 10.1016/s2468-1253(22)00271-0
  +Save
• Similar Cure Rates With Different Routes: Can It Be Generalized?
  Clinical Gastroenterology and Hepatology 2022 DOI: 10.1016/j.cgh.2022.10.011
  +Save
• Emerging Biomarkers for Screening and Management of Celiac Disease
  BioMed Research International 2022 DOI: 10.1155/2022/2756242
  +Save
• A New Window to Favorable Outcome in Acute-on-Chronic Liver Failure
  American Journal of Gastroenterology 2022 DOI: 10.14309/ajg.0000000000001703
  +Save
• Nonalcoholic Fatty Liver Disease
  New England Journal of Medicine 2022 DOI: 10.1056/nejmc2118255
  +Save
• Hyperuricaemia as a predictor of hospital outcome in patients with sepsis: results of a prospective study
  The Egyptian Journal of Internal Medicine 2021 DOI: 10.1186/s43162-021-00079-4
  +Save
• A rare presentation of myelomatous pleural effusion in immunoglobulin g subtype of multiple myeloma
  Oncology Journal of India 2021 DOI: 10.4103/oji.oji_32_20
  +Save
• Anticoagulant associated stroke, an observational retrospective study in tertiary care hospital in north india
  2019
  +Save